DOLOMITE NEAT ID Network Study: A prospective, multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women (208759)

First published 30/05/2018

Last updated 06/01/2025

EU PAS number:

EUPAS24237

Study

Ongoing

Documents

Study protocol

Initial protocol

viiv-208759-protocol-redact

English (249.71 KB - PDF)View document

Updated protocol

viiv-208759-protocol1-redact

First published: 22/02/2024

English (1.55 MB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs